SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,097,000 | -24.2% | 600,000 | 0.0% | 0.43% | -24.7% |
| Q3 2014 | $1,448,000 | +22.6% | 600,000 | 0.0% | 0.57% | +25.6% |
| Q2 2014 | $1,181,000 | +16.1% | 600,000 | 0.0% | 0.45% | +12.7% |
| Q1 2014 | $1,017,000 | +13.4% | 600,000 | 0.0% | 0.40% | +10.7% |
| Q4 2013 | $897,000 | – | 600,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $4,916,000 | 4.33% |
| SYMPHONY ASSET MANAGEMENT LLC | 19,840,000 | $38,948,000 | 4.05% |
| SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $38,695,000 | 4.00% |
| MACKAY SHIELDS LLC | 31,471,000 | $61,916,000 | 3.41% |
| Sage Capital Management, LLC | 1,500,000 | $2,942,000 | 2.98% |
| ALTEGRIS ADVISORS, L.L.C. | 250,000 | $491,000 | 2.56% |
| Wellesley Asset Management | 16,220 | $31,923,000 | 2.01% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $16,883,000 | 1.62% |
| CAMDEN ASSET MANAGEMENT L P /CA | 13,862,000 | $27,213,000 | 1.58% |
| Calamos Wealth Management LLC | 2,061,000 | $4,045,000 | 1.15% |